KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Accured Expenses: 2015-2025

Historic Change in Accured Expenses for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $45.3 million.

  • Medpace Holdings' Change in Accured Expenses rose 247.76% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.5 million, marking a year-over-year increase of 47.16%. This contributed to the annual value of $16.9 million for FY2024, which is 79.43% down from last year.
  • Latest data reveals that Medpace Holdings reported Change in Accured Expenses of $45.3 million as of Q3 2025, which was up 27.85% from $35.4 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Change in Accured Expenses registered a high of $45.3 million during Q3 2025, and its lowest value of -$23.2 million during Q1 2025.
  • In the last 3 years, Medpace Holdings' Change in Accured Expenses had a median value of $22.0 million in 2024 and averaged $14.2 million.
  • Examining YoY changes over the last 5 years, Medpace Holdings' Change in Accured Expenses showed a top increase of 626.34% in 2021 and a maximum decrease of 471.60% in 2021.
  • Medpace Holdings' Change in Accured Expenses (Quarterly) stood at $1.5 million in 2021, then surged by 215.90% to $4.6 million in 2022, then soared by 486.80% to $27.2 million in 2023, then plummeted by 89.14% to $2.9 million in 2024, then skyrocketed by 247.76% to $45.3 million in 2025.
  • Its Change in Accured Expenses was $45.3 million in Q3 2025, compared to $35.4 million in Q2 2025 and -$23.2 million in Q1 2025.